Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $NRC vs $VMD | Chartloom

Compare

$NRC vs $VMD

National Research Corp · Viemed Healthcare Inc

NRC

National Research Corp

VMD

Viemed Healthcare Inc

Compare $NRC vs $VMD

Comparing National Research Corp and Viemed Healthcare Inc

NRCNational Research Corp

VMDViemed Healthcare Inc

NRCNational Research Corp

Market cap

$452M

P/E (TTM)

81.00x

Forward P/E (NTM)

21.29x

Forward P/S (NTM)

3.04x

Rev growth (TTM)

-0.2%

YTD performance

13.3%

52W performance

78.0%

FCF yield

4.8%

VMDViemed Healthcare Inc

Market cap

$372M

P/E (TTM)

27.49x

Forward P/E (NTM)

19.32x

Forward P/S (NTM)

1.10x

Rev growth (TTM)

25.2%

YTD performance

34.2%

52W performance

40.8%

FCF yield

7.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NRC

VMD

Detailed metrics comparison

NRC

National Research Corp

VMD

Viemed Healthcare Inc

Market Cap

NRC$452M

VMD$372M

Enterprise Value

NRC$539M

VMD$368M

Price

NRC$20.43

VMD$9.69

P/E Ratio

NRC81.00x

VMD27.49x

P/S Ratio

NRC3.23x

VMD1.23x

EV/Sales

NRC3.85x

VMD1.22x

EV/EBITDA

NRC23.06x

VMD6.66x

P/B Ratio

NRC68.67x

VMD2.52x

P/FCF Ratio

NRC20.90x

VMD12.71x

EV/FCF

NRC24.91x

VMD12.58x

PEG Ratio

NRCN/A

VMD1.16x

Forward P/E (NTM)

NRC21.29x

VMD19.32x

Forward P/S (NTM)

NRC3.04x

VMD1.10x

Revenue (TTM)

NRC$140M

VMD$302M

Revenue Growth (YoY)

NRC-0.2%

VMD25.2%

Forward Rev Growth

NRC8.3%

VMD11.2%

Gross Margin (TTM)

NRC61.7%

VMD57.5%

Operating Margin (TTM)

NRC10.5%

VMD7.5%

EBITDA Margin (TTM)

NRC16.7%

VMD18.1%

Net Margin (TTM)

NRC4.0%

VMD4.8%

FCF Margin (TTM)

NRC15.5%

VMD9.7%

Net Income (TTM)

NRC$6M

VMD$14M

FCF (TTM)

NRC$22M

VMD$29M

EPS (TTM)

NRC$0.25

VMD$0.35

ROE (TTM)

NRC48.5%

VMD10.3%

ROA (TTM)

NRC4.3%

VMD7.2%

ROIC (TTM)

NRC6.2%

VMD9.5%

Cash

NRC$3M

VMD$11M

Debt

NRC$90M

VMD$7M

Net Cash/Debt

NRC$-87M

VMD$4M

Current Ratio (TTM)

NRC0.65x

VMD1.13x

Quick Ratio (TTM)

NRC0.50x

VMD0.90x

Debt/Equity (TTM)

NRC13.75x

VMD0.05x

Debt/Assets (TTM)

NRC0.0%

VMD0.0%

Interest Coverage (TTM)

NRCN/A

VMDN/A

Net Debt/EBITDA (TTM)

NRC0.00x

VMD0.00x

Beta

NRC0.26

VMD1.05

52W Performance

NRC78.0%

VMD40.8%

YTD Performance

NRC13.3%

VMD34.2%

% from 52W High

NRC-13.7%

VMD-23.2%

% from 52W Low

NRC85.5%

VMD60.2%

Asset Turnover (TTM)

NRC1.03x

VMD1.50x

FCF Yield (TTM)

NRC4.8%

VMD7.9%

Earnings Yield (TTM)

NRC1.2%

VMD3.9%

Dividend Yield (TTM)

NRC2.8%

VMDN/A

Rule of 40

NRC15.2

VMD34.9

EV/GP/RG

NRC0.98

VMD0.18

Ticker research

View NRC research View VMD research

Metric	NRC National Research Corp	VMD Viemed Healthcare Inc
Market & Valuation
Market Cap	$452M	$372M
Enterprise Value	$539M	$368M
Price	$20.43	$9.69
P/E Ratio	81.00x	27.49x
P/S Ratio	3.23x	1.23x
EV/Sales	3.85x	1.22x
EV/EBITDA	23.06x	6.66x
P/B Ratio	68.67x	2.52x
P/FCF Ratio	20.90x	12.71x
EV/FCF	24.91x	12.58x
PEG Ratio	N/A	1.16x
Forward P/E (NTM)	21.29x	19.32x
Forward P/S (NTM)	3.04x	1.10x
Revenue & Growth
Revenue (TTM)	$140M	$302M
Revenue Growth (YoY)	-0.2%	25.2%
Forward Rev Growth	8.3%	11.2%
Profitability
Gross Margin (TTM)	61.7%	57.5%
Operating Margin (TTM)	10.5%	7.5%
EBITDA Margin (TTM)	16.7%	18.1%
Net Margin (TTM)	4.0%	4.8%
FCF Margin (TTM)	15.5%	9.7%
Net Income (TTM)	$6M	$14M
FCF (TTM)	$22M	$29M
EPS (TTM)	$0.25	$0.35
ROE (TTM)	48.5%	10.3%
ROA (TTM)	4.3%	7.2%
ROIC (TTM)	6.2%	9.5%
Financial Health
Cash	$3M	$11M
Debt	$90M	$7M
Net Cash/Debt	$-87M	$4M
Current Ratio (TTM)	0.65x	1.13x
Quick Ratio (TTM)	0.50x	0.90x
Debt/Equity (TTM)	13.75x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.26	1.05
52W Performance	78.0%	40.8%
YTD Performance	13.3%	34.2%
% from 52W High	-13.7%	-23.2%
% from 52W Low	85.5%	60.2%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	1.50x
FCF Yield (TTM)	4.8%	7.9%
Earnings Yield (TTM)	1.2%	3.9%
Dividend Yield (TTM)	2.8%	N/A
Other
Rule of 40	15.2	34.9
EV/GP/RG	0.98	0.18
Ticker research	View NRC research	View VMD research

Valuation

P/E Ratio

VMD

27.49x

NRC

81.00x

P/S Ratio

VMD

1.23x

NRC

3.23x

EV/FCF

VMD

12.58x

NRC

24.91x

Growth & revenue

Revenue Growth TTM

VMD

25.2%

NRC

-0.2%

Forward Revenue Growth

VMD

11.2%

NRC

8.3%

Profitability & performance

Gross Margin

NRC

61.7%

VMD

57.5%

ROE

NRC

48.5%

VMD

10.3%

FCF Yield %

VMD

7.9%

NRC

4.8%

52-Week Performance

NRC

78.0%

VMD

40.8%

Detailed metrics comparison

NRC

National Research Corp

VMD

Viemed Healthcare Inc

Market Cap

NRC$452M

VMD$372M

Enterprise Value

NRC$539M

VMD$368M

Price

NRC$20.43

VMD$9.69

P/E Ratio

NRC81.00x

VMD27.49x

P/S Ratio

NRC3.23x

VMD1.23x

EV/Sales

NRC3.85x

VMD1.22x

EV/EBITDA

NRC23.06x

VMD6.66x

P/B Ratio

NRC68.67x

VMD2.52x

P/FCF Ratio

NRC20.90x

VMD12.71x

EV/FCF

NRC24.91x

VMD12.58x

PEG Ratio

NRCN/A

VMD1.16x

Forward P/E (NTM)

NRC21.29x

VMD19.32x

Forward P/S (NTM)

NRC3.04x

VMD1.10x

Revenue (TTM)

NRC$140M

VMD$302M

Revenue Growth (YoY)

NRC-0.2%

VMD25.2%

Forward Rev Growth

NRC8.3%

VMD11.2%

Gross Margin (TTM)

NRC61.7%

VMD57.5%

Operating Margin (TTM)

NRC10.5%

VMD7.5%

EBITDA Margin (TTM)

NRC16.7%

VMD18.1%

Net Margin (TTM)

NRC4.0%

VMD4.8%

FCF Margin (TTM)

NRC15.5%

VMD9.7%

Net Income (TTM)

NRC$6M

VMD$14M

FCF (TTM)

NRC$22M

VMD$29M

EPS (TTM)

NRC$0.25

VMD$0.35

ROE (TTM)

NRC48.5%

VMD10.3%

ROA (TTM)

NRC4.3%

VMD7.2%

ROIC (TTM)

NRC6.2%

VMD9.5%

Cash

NRC$3M

VMD$11M

Debt

NRC$90M

VMD$7M

Net Cash/Debt

NRC$-87M

VMD$4M

Current Ratio (TTM)

NRC0.65x

VMD1.13x

Quick Ratio (TTM)

NRC0.50x

VMD0.90x

Debt/Equity (TTM)

NRC13.75x

VMD0.05x

Debt/Assets (TTM)

NRC0.0%

VMD0.0%

Interest Coverage (TTM)

NRCN/A

VMDN/A

Net Debt/EBITDA (TTM)

NRC0.00x

VMD0.00x

Beta

NRC0.26

VMD1.05

52W Performance

NRC78.0%

VMD40.8%

YTD Performance

NRC13.3%

VMD34.2%

% from 52W High

NRC-13.7%

VMD-23.2%

% from 52W Low

NRC85.5%

VMD60.2%

Asset Turnover (TTM)

NRC1.03x

VMD1.50x

FCF Yield (TTM)

NRC4.8%

VMD7.9%

Earnings Yield (TTM)

NRC1.2%

VMD3.9%

Dividend Yield (TTM)

NRC2.8%

VMDN/A

Rule of 40

NRC15.2

VMD34.9

EV/GP/RG

NRC0.98

VMD0.18

Ticker research

View NRC research View VMD research

Metric	NRC National Research Corp	VMD Viemed Healthcare Inc
Market & Valuation
Market Cap	$452M	$372M
Enterprise Value	$539M	$368M
Price	$20.43	$9.69
P/E Ratio	81.00x	27.49x
P/S Ratio	3.23x	1.23x
EV/Sales	3.85x	1.22x
EV/EBITDA	23.06x	6.66x
P/B Ratio	68.67x	2.52x
P/FCF Ratio	20.90x	12.71x
EV/FCF	24.91x	12.58x
PEG Ratio	N/A	1.16x
Forward P/E (NTM)	21.29x	19.32x
Forward P/S (NTM)	3.04x	1.10x
Revenue & Growth
Revenue (TTM)	$140M	$302M
Revenue Growth (YoY)	-0.2%	25.2%
Forward Rev Growth	8.3%	11.2%
Profitability
Gross Margin (TTM)	61.7%	57.5%
Operating Margin (TTM)	10.5%	7.5%
EBITDA Margin (TTM)	16.7%	18.1%
Net Margin (TTM)	4.0%	4.8%
FCF Margin (TTM)	15.5%	9.7%
Net Income (TTM)	$6M	$14M
FCF (TTM)	$22M	$29M
EPS (TTM)	$0.25	$0.35
ROE (TTM)	48.5%	10.3%
ROA (TTM)	4.3%	7.2%
ROIC (TTM)	6.2%	9.5%
Financial Health
Cash	$3M	$11M
Debt	$90M	$7M
Net Cash/Debt	$-87M	$4M
Current Ratio (TTM)	0.65x	1.13x
Quick Ratio (TTM)	0.50x	0.90x
Debt/Equity (TTM)	13.75x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.26	1.05
52W Performance	78.0%	40.8%
YTD Performance	13.3%	34.2%
% from 52W High	-13.7%	-23.2%
% from 52W Low	85.5%	60.2%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	1.50x
FCF Yield (TTM)	4.8%	7.9%
Earnings Yield (TTM)	1.2%	3.9%
Dividend Yield (TTM)	2.8%	N/A
Other
Rule of 40	15.2	34.9
EV/GP/RG	0.98	0.18
Ticker research	View NRC research	View VMD research